Immunic Therapeutics advances MS Drug , Phase 2 CALLIPER trial readout in April

By Proactive Investors / March 11, 2025 / www.youtube.com / Article Link


Immunic Therapeutics Chief Scientific Officer Dr. Hella Kohlhof joined Steve Darling from Proactive to discuss the company's ...

Recent News

Gold stocks down as risk on move continues

May 05, 2025 / www.canadianminingreport.com

Mixed outlook for resources on new Canadian government

May 05, 2025 / www.canadianminingreport.com

Gold's Bull Market Pullbacks

April 28, 2025 / www.canadianminingreport.com

Gold stocks down on metal drop

April 28, 2025 / www.canadianminingreport.com

Investment banks ahead of the gold price, institutions still behind

April 21, 2025 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok